APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

143 hedge funds and large institutions have $1.53B invested in Apellis Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 63 increasing their positions, 34 reducing their positions, and 23 closing their positions.

Holders
143
Holders Change
+10
Holders Change %
+7.52%
% of All Funds
3.16%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
35
Increased
63
Reduced
34
Closed
23
Calls
$5.35M
Puts
$11.4M
Net Calls
-$6.06M
Net Calls Change
-$13.1M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$278M
2
Victory Capital Management
2
Victory Capital Management
Texas
$100M
3
FCM
3
Farallon Capital Management
California
$53.6M
4
BlackRock
4
BlackRock
New York
$156M
5
Jennison Associates
5
Jennison Associates
New York
$56M

Top Sellers

1
Barclays
1
Barclays
United Kingdom
$5.09M
2
BC
2
Boxer Capital
California
$0
3
LGM
3
Logos Global Management
California
$0
4
VP
4
venBio Partners
California
$13.4M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$278M 10,371,998 +6,054,734 +140%
BlackRock
2
BlackRock
New York
$156M 5,816,260 +1,058,755 +22%
HA
3
HHLR Advisors
Cayman Islands
$135M 5,028,289 +350,000 +7%
Victory Capital Management
4
Victory Capital Management
Texas
$100M 3,732,830 +1,563,481 +72%
Vanguard Group
5
Vanguard Group
Pennsylvania
$81.3M 3,033,471 +619,157 +26%
State Street
6
State Street
Massachusetts
$66.9M 2,498,764 +199,529 +9%
CAM
7
Cormorant Asset Management
Massachusetts
$60.7M 2,266,108 -433,892 -16%
Jennison Associates
8
Jennison Associates
New York
$56M 2,089,517 +984,486 +89%
FCM
9
Farallon Capital Management
California
$53.6M 2,000,000 +1,500,000 +300%
Millennium Management
10
Millennium Management
New York
$36.4M 1,357,586 +774,980 +133%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$33.5M 1,250,870 +459,207 +58%
Fidelity International
12
Fidelity International
Bermuda
$29.6M 1,104,349 -289,936 -21%
EP
13
Eversept Partners
New York
$24.1M 899,474 +589,065 +190%
BBA
14
Baker Bros. Advisors
New York
$24M 896,551 +399,582 +80%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$23.5M 877,200 +617,200 +237%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$22.2M 828,049 +170,112 +26%
Citadel Advisors
17
Citadel Advisors
Florida
$19.7M 734,840 +178,480 +32%
Northern Trust
18
Northern Trust
Illinois
$18.3M 684,869 +105,867 +18%
Goldman Sachs
19
Goldman Sachs
New York
$17M 634,717 +168,482 +36%
FT
20
Fiduciary Trust
Massachusetts
$15.9M 591,712 +3,174 +0.5%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$13.9M 518,534 -20,900 -4%
DCM
22
Driehaus Capital Management
Illinois
$13.7M 512,470 +55,806 +12%
VP
23
venBio Partners
California
$13.4M 501,584 -498,416 -50%
CS
24
Candriam SCA
Luxembourg
$11.7M 392,200 – –
Two Sigma Investments
25
Two Sigma Investments
New York
$11.6M 431,339 +214,562 +99%
1
2 3 4 5